Interferon-beta: treatment option against COVID-19

Autor:	Muhammad Imran, Faiz Ul Haq, Muhammad Usman Ghani Khan, Ayesha Muazzam, Sania Ahmad, Hajrah Farooq, Rabia Bashir, Javeria Iqbal, Sara Arif
Rok vydání:	2020
Předmět:	COVID-19 Coronavirus disease 2019 (COVID-19) Interferon beta SARS-CoV-2 business.industry viruses virus diseases Treatment options lcsh:Geriatrics Coronavirus lcsh:RC952-954.6 antiviral agents Cancer research Interferon-β Medicine business
Zdroj:	Geriatric Care, Vol 6, Iss 3 (2020)
ISSN:	2465-1397 2465-1109
DOI:	10.4081/gc.2020.9093
Popis:	In December 2019, an increasing number of cases of novel coronavirus (2019-nCoV) that were linked to seafood wholesale market have identified in Wuhan, China. Taxonomist declared 2019-nCoV as severe acute respiratory syndrome coronavirus- 2 (SARS-CoV-2) and the disease termed as COVID-19. Importantly, there is no approved drugs or vaccine against SARS-CoV-2. Current review is related to address treatment option for COVID-19. Interferon-β have shown significant activity against previous outbreak of SARS-CoV and MERS-CoV. Faced with an ongoing pandemic of SARS-CoV-2 and lack of effective treatment options, identifying compounds with antiviral activity has become a high priority. Efficacy of these treatments is still unclear. Therefore, final analysis is important to develop better treatment strategies for ongoing pandemic.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17154975bcf615872b38c92757ab445f https://doi.org/10.4081/gc.2020.9093 Zobrazit plný text záznamu